Commentary
Good and bad fever
Unit of Cytokines & Inflammation, Department of Infection and Epidemiology, Institut Pasteur, 28 rue Dr Roux, F-75015 Paris, France
Critical Care 2012, 16:119 doi:10.1186/cc11237
See related research by Egi et al., http://ccforum.com/content/16/1/R33
Published: 20 March 2012Abstract
Fever is considered a key actor of innate immunity aimed to fight infection. A new investigation reports an association of the use of antipyretic drugs with poorer outcome among patients with sepsis. In contrast, high temperature in non-infectious intensive care patients is associated with higher mortality.
